Key result
An XGBoost-based prediction model incorporating left atrial appendage parameters and clinical variables effectively predicted 12-month atrial fibrillation recurrence after radiofrequency ablation with an AUC of 0.87 and accuracy of 86.1%.
Why the study?
RFA is used to treat AF but is not always successful in maintaining sinus rhythm, prompting the development of a prediction model for post-ablation recurrence.
Can an XGBoost-based model accurately predict 12-month recurrence of AF after radiofrequency ablation?
Cohort (n=359)
No
Can an XGBoost-based model accurately predict 12-month recurrence of AF after radiofrequency ablation?
Answers are grounded in this paper and cite their sources.
An XGBoost-based machine learning model using 6 key clinical and echocardiographic parameters can effectively predict 12-month AF recurrence after radiofrequency ablation.
BACKGROUND: Atrial fibrillation (AF) is a common heart rhythm disorder that can lead to complications such as stroke and heart failure. Radiofrequency ablation (RFA) is a procedure used to treat AF, but it is not always successful in maintaining a normal heart rhythm. This study aimed to construct a clinical prediction model based on extreme gradient boosting (XGBoost) for AF recurrence 12 months after ablation. METHODS: The 27-dimensional data of 359 patients with AF undergoing RFA in the First Affiliated Hospital of Soochow University from October 2018 to November 2021 were retrospectively analysed. We adopted the logistic regression, support vector machine (SVM), random forest (RF) and XGBoost methods to conduct the experiment. To evaluate the performance of the prediction, we used the area under the receiver operating characteristic curve (AUC), the area under the precision-recall curve (AP), and calibration curves of both the training and testing sets. Finally, Shapley additive explanations (SHAP) were utilized to explain the significance of the variables. RESULTS: Of the 27-dimensional variables, ejection fraction (EF) of the left atrial appendage (LAA), N-terminal probrain natriuretic peptide (NT-proBNP), global peak longitudinal strain of the LAA (LAAGPLS), left atrial diameter (LAD), diabetes mellitus (DM) history, and female sex had a significant role in the predictive model. The experimental results demonstrated that XGBoost exhibited the best performance among these methods, and the accuracy, specificity, sensitivity, precision and F1 score (a measure of test accuracy) of XGBoost were 86.1%, 89.7%, 71.4%, 62.5% and 0.67, respectively. In addition, SHAP analysis also proved that the 6 parameters were decisive for the effect of the XGBoost-based prediction model. CONCLUSIONS: We proposed an effective model based on XGBoost that can be used to predict the recurrence of AF patients after RFA. This prediction result can guide treatment decisions and help to optimize the management of AF.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2023) conducted a cohort in Atrial fibrillation (n=359). XGBoost prediction model vs. Logistic regression, SVM, and Random Forest models was evaluated on Prediction of 12-month AF recurrence (AUC on testing set). An XGBoost-based prediction model incorporating left atrial appendage parameters and clinical variables effectively predicted 12-month atrial fibrillation recurrence after radiofrequency ablation with an AUC of 0.87 and accuracy of 86.1%.
Synapse has enriched 10 related papers. Consider them for comparative context: